Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

573

Surgery for small cell lung cancer.

Alberto de Hoyos1, Malcolm M DeCamp1

  • 1Division of Thoracic Surgery, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 676 North Saint Clair Street, Suite 650, Chicago, IL 60611, USA.

Thoracic Surgery Clinics
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sublobar Resection in Stage I Non-Small Cell Lung Cancer With Lymphovascular Invasion.

Annals of thoracic surgery short reports·2026
Same author

Sublobar Resection in Stage I Lung Cancer With Tumor Spread Through Air Spaces.

Annals of thoracic surgery short reports·2025
Same author

The Presence of Both Tumor Spread through Air Spaces and Visceral Pleural Invasion May Increase Tumor Recurrence Risk in Non-Small Cell Lung Cancer.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·2025
Same author

Lung Transplant Outcomes in the Veterans Health Administration.

The Annals of thoracic surgery·2025
Same author

Effect of Deployed Cardiothoracic Surgeons on Clinical Outcomes in U.S. Service Members with Thoracic Trauma in Operation Iraqi Freedom.

Military medicine·2025
Same author

Intercostal nerve cryoablation as part of an opioid-sparing protocol reduces opioid and epidural use after lung transplant.

JHLT open·2025

Small-cell lung cancer (SCLC) is diagnosed in 14% of lung cancer patients, often at advanced stages. For early-stage SCLC, surgery plus chemotherapy is beneficial, but the role of radiotherapy is debated.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Background:

  • Small-cell lung cancer (SCLC) accounts for approximately 14% of all lung cancer diagnoses.
  • The majority of SCLC patients present with locally advanced or metastatic disease, necessitating nonoperative treatment with chemotherapy, radiotherapy, or combined modalities.
  • A small fraction of SCLC patients are diagnosed with early-stage disease, potentially benefiting from surgical intervention.

Purpose of the Study:

  • To evaluate the role and efficacy of radiotherapy in conjunction with surgery and chemotherapy for early-stage small-cell lung cancer.
  • To clarify the controversial indications for radiotherapy in resectable SCLC cases.

Main Methods:

  • Review of existing literature and clinical trial data concerning multimodal treatment for early-stage SCLC.
Keywords:
Early-stage small cell lung cancerLobectomyLung resectionSmall cell lung cancer

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Related Experiment Videos

Last Updated: Apr 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

573
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
  • Analysis of treatment outcomes, including survival rates and recurrence patterns, for patients receiving surgery, chemotherapy, and/or radiotherapy.
  • Comparative analysis of treatment strategies to determine the optimal approach for early-stage SCLC.

    • Main Results:

    • Surgical resection combined with chemotherapy is a recognized treatment for early-stage SCLC.
    • The addition of radiotherapy to surgery and chemotherapy in early-stage SCLC presents a complex treatment decision.
    • Evidence supporting the routine use of radiotherapy in this specific patient group is currently limited and debated.

    Conclusions:

    • While surgery and chemotherapy are established treatments for early-stage SCLC, the specific benefit of adding radiotherapy requires further investigation.
    • The optimal multimodality treatment strategy for early-stage SCLC, particularly concerning the role of radiotherapy, remains an area of active clinical research and debate.
    • Further studies are needed to definitively establish the indications and impact of radiotherapy in resectable SCLC.